Predicting an allograft's fate

Slides:



Advertisements
Similar presentations
Navdeep Tangri, Paul V.J. Komenda, Claudio Rigatto 
Advertisements

Frederik Persson, Peter Rossing  Kidney International Supplements 
Renal manifestations in Fabry disease and therapeutic options
Tuberculosis and tubulointerstitial nephritis: an intriguing puzzle
Blaithin A. McMahon, Patrick Thomas Murray  Kidney International 
From secondary to primary prevention of progressive renal disease: The case for screening for albuminuria  Paul E. De Jong, Barry M. Brenner  Kidney International 
Shining light on vitamin D trials in chronic kidney disease
Prehypertension and chronic kidney disease: the ox or the plow?
Status of chronic kidney disease prevention programs: International Federation of Kidney Foundation Members 2005/2007  Joanna M. Smith, Susan A. Mott,
Volume 80, Issue 10, Pages (November 2011)
John P. Middleton, Patrick H. Pun  Kidney International 
‘Progressive diabetic nephropathy. How useful is microalbuminuria
Rise or fall of glomerular filtration rate: does it matter?
Yasuhiro Hamada, Masafumi Fukagawa  Kidney International 
Better nephrology for mice—and man
Volume 77, Issue 8, Pages (April 2010)
The implications of anatomical and functional changes of the aging kidney: with an emphasis on the glomeruli  Richard J. Glassock, Andrew D. Rule  Kidney.
Jeffrey C. Fink, Glenn M. Chertow  Kidney International 
Volume 78, Issue 12, Pages (December 2010)
Volume 75, Issue 10, Pages (May 2009)
Volume 77, Issue 1, Pages 5-6 (January 2010)
Infection and chronic allograft dysfunction
Comorbidity and confounding in end-stage renal disease
D. Batlle, P. Ramadugu, M.J. Soler  Kidney International 
The importance of increased dialysis and anemia management for infant survival in pregnant women on hemodialysis  Sai Subhodhini Reddy, Jean L. Holley 
Volume 74, Issue 3, Pages (August 2008)
Volume 70, Issue 11, Pages (December 2006)
Manjula Kurella Tamura, Kristine Yaffe  Kidney International 
Volume 89, Issue 5, Pages (May 2016)
A novel classification for IgA nephropathy
Nephrology Crosswords: Hemodialysis
Dyslipidemia in children with chronic kidney disease
Timothy A. Sutton, Pierre C. Dagher  Kidney International 
U-shaped effect of eGFR and mortality
Modulating kidney transplant interstitial fibrosis and tubular atrophy: is the RAAS an important target?  Hatem Amer, Matthew D. Griffin  Kidney International 
Disaster nephrology: crush injury and beyond
Volume 81, Issue 6, Pages (March 2012)
Navdeep Tangri, Paul V.J. Komenda, Claudio Rigatto 
Volume 72, Issue 2, Pages (July 2007)
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Tilman B. Drüeke, Ziad A. Massy  Kidney International 
Volume 63, Pages S38-S42 (February 2003)
Volume 85, Issue 5, Pages (May 2014)
Nephrology Crossword: Peritoneal Dialysis
Calcium sensing in podocytes
Methods for guideline development
The global challenge of chronic kidney disease
Nephrology Crossword: Glomerulonephritis
Volume 80, Issue 3, Pages (August 2011)
Prehypertension: is it relevant for nephrologists?
Volume 73, Issue 9, Pages (May 2008)
Volume 82, Issue 9, Pages (November 2012)
Volume 81, Issue 1, Pages 7-9 (January 2012)
What makes plaques vulnerable in CKD
Volume 65, Issue 2, Pages (February 2004)
Volume 80, Issue 10, Pages (November 2011)
Charles A. Herzog  Kidney International 
Tobias Breidthardt, Alexandre Mebazaa, Christian E. Mueller 
Adiponectin: good, bad, or just plain ugly?
The international realities of live donor kidney transplantation
Where vaptans do and do not fit in the treatment of hyponatremia
Volume 53, Issue 5, Pages (May 1998)
Volume 80, Issue 9, Pages (November 2011)
Glomerular monocytes predict worse outcomes after acute renal allograft rejection independent of C4d status  Kathryn J. Tinckam, Ognjenka Djurdjev, Alex.
Volume 65, Issue 5, Pages (May 2004)
Volume 72, Issue 12, (December 2007)
Daniel L. Roden, Shane T. Grey  Kidney International 
The Ebf1 knockout mouse and glomerular maturation
Volume 79, Issue 10, Pages (May 2011)
Presentation transcript:

Predicting an allograft's fate Thomas Fehr, Clemens D. Cohen  Kidney International  Volume 80, Issue 12, Pages 1254-1255 (December 2011) DOI: 10.1038/ki.2011.328 Copyright © 2011 International Society of Nephrology Terms and Conditions

Figure 1 Progression of chronic allograft damage. A ‘transcriptomic window,’ as suggested by the study by Naesens et al.,5 may indicate which histologically unremarkable allografts will rapidly progress to morphological and functional alterations. A future therapeutic intervention should halt this progression or even lead to a regression of established damage (both indicated in red). GFR, glomerular filtration rate; IF/TA, interstitial fibrosis/tubular atrophy. Kidney International 2011 80, 1254-1255DOI: (10.1038/ki.2011.328) Copyright © 2011 International Society of Nephrology Terms and Conditions